Assignee
ONCORESPONSE INC
US·4 granted patents·7 pending applications·7 citations·filing 2020–2025
Top patents by PatentIndex Score
11 records- 0191US11034770B2Immunomodulatory antibodies and methods of use thereofONCORESPONSE INC·Filed 2020·Granted Jun 15, 2021·3 cites·11 claims
- 0290US11827715B2Human CD163 antibodies and uses thereofONCORESPONSE INC·Filed 2021·Granted Nov 28, 2023·2 cites·29 claims
- 0388US11634501B2Immunomodulatory antibodies and methods of use thereofONCORESPONSE INC·Filed 2020·Granted Apr 25, 2023·2 cites·25 claims
- 0481US12195549B2Immunomodulatory antibodies and methods of use thereofONCORESPONSE INC·Filed 2023·Granted Jan 14, 2025·0 cites·14 claims
- 0581US2024239914A1Human cd163 antibodies and uses thereofONCORESPONSE INC·Filed 2023·Application pending·0 cites
- 0665US2025002577A1Lilrb2/1 antibody products and methodsONCORESPONSE INC·Filed 2024·Application pending·0 cites
- 0764US2023181732A1Combinations of immunotherapies and uses thereofONCORESPONSE INC·Filed 2022·Application pending·0 cites
- 0864US2024132589A1Lilrb2 antibody products and methodsONCORESPONSE INC·Filed 2023·Application pending·0 cites
- 0958US2024084029A1Use of immunomodulatory antibodies to treat fibrotic diseasesONCORESPONSE INC·Filed 2022·Application pending·0 cites
- 1056US2026000756A1Combinations of immunotherapies and uses thereofONCORESPONSE INC·Filed 2025·Application pending·0 cites
- 1155US2024092926A1Immunomodulatory antibodies and uses thereofONCORESPONSE INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →